Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Microba FPO [Map] (MAP.AX)

Microba FPO [Map] (MAP.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Microba FPO [Map] 324 Queen Street Level 10 Brisbane QLD 4000 AUS

https://www.microba.com P: 130-097-4621 F: 130-097-4621

Sector:

N/A

INDUSTRY GROUPING:

N/A

Description:

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are: Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.

Key Statistics

Overview:

Market Capitalization, $K 51,762
Shares Outstanding, K 608,963
% of Institutional Shareholders 0.01%

Financials:

Annual Sales, $ 15,669 K
Annual Net Income, $ -14,939 K

Growth:

1-Year Return -57.95%
3-Year Return -77.63%
5-Year Return 0.00%

Per-Share Information:

Next Earnings Date N/A
Earnings Per Share ttm -0.03
Dividend Payout Ratio 0.00%

MAP.AX Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Return-on-Equity % -40.54%
Return-on-Assets % -28.33%
Profit Margin % -95.34%
Debt/Equity 0.05
Price/Sales 2.95
Price/Book 1.72
Book Value/Share 0.05
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar